203 related articles for article (PubMed ID: 32207983)
1. Covid-19 infection and mortality: a physiologist's perspective enlightening clinical features and plausible interventional strategies.
Abassi ZA; Skorecki K; Heyman SN; Kinaneh S; Armaly Z
Am J Physiol Lung Cell Mol Physiol; 2020 May; 318(5):L1020-L1022. PubMed ID: 32207983
[No Abstract] [Full Text] [Related]
2. Coronavirus disease 2019 and the cardiovascular system: Impacts and implications.
Gupta MD; Girish MP; Yadav G; Shankar A; Yadav R
Indian Heart J; 2020; 72(1):1-6. PubMed ID: 32423554
[No Abstract] [Full Text] [Related]
3. [Renin-Angiotensin-System (RAS) and COVID-19 - On The Prescription of RAS Blockers].
Kreutz R; Abd El-Hady Algharably E; Ganten D; Messerli F
Pneumologie; 2020 Sep; 74(9):611-614. PubMed ID: 32916743
[No Abstract] [Full Text] [Related]
4. Angiotensin II suppression in SARS-CoV-2 infection: a therapeutic approach.
Lamas-Barreiro JM; Alonso-Suárez M; Fernández-Martín JJ; Saavedra-Alonso JA
Nefrologia (Engl Ed); 2020; 40(3):213-216. PubMed ID: 32456945
[No Abstract] [Full Text] [Related]
5. Would ACEIs/ARBs be beneficial for COVID-19 patients without hypertension?
Huang Y; Xie C; Chen X; Hong Q; Huang H
Pharmacol Res; 2020 Sep; 159():104959. PubMed ID: 32505834
[No Abstract] [Full Text] [Related]
6. Angiotensin converting enzyme-2 as therapeutic target in COVID-19.
Roshanravan N; Ghaffari S; Hedayati M
Diabetes Metab Syndr; 2020; 14(4):637-639. PubMed ID: 32428864
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 and fat embolism: a hypothesis to explain the severe clinical outcome in people with obesity.
Cinti S; Graciotti L; Giordano A; Valerio A; Nisoli E
Int J Obes (Lond); 2020 Aug; 44(8):1800-1802. PubMed ID: 32514077
[No Abstract] [Full Text] [Related]
8. The role of ACEIs/ARBs in COVID-19: Friend or foe?
Zhou Z; Qiu Y; Tao J
Med Hypotheses; 2020 Sep; 142():109810. PubMed ID: 32413701
[No Abstract] [Full Text] [Related]
9. Expression of angiotensin-converting enzyme 2 and proteases in COVID-19 patients: A potential role of cellular FURIN in the pathogenesis of SARS-CoV-2.
Drak Alsibai K
Med Hypotheses; 2020 Oct; 143():109893. PubMed ID: 32512290
[TBL] [Abstract][Full Text] [Related]
10. The Effect of Coronavirus Disease 2019 on Cardiovascular Diseases.
Askin L; Tanrıverdi O; Askin HS
Arq Bras Cardiol; 2020 Jun; 114(5):817-822. PubMed ID: 32491073
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
Hoffmann M; Kleine-Weber H; Schroeder S; Krüger N; Herrler T; Erichsen S; Schiergens TS; Herrler G; Wu NH; Nitsche A; Müller MA; Drosten C; Pöhlmann S
Cell; 2020 Apr; 181(2):271-280.e8. PubMed ID: 32142651
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 and Cardiovascular Disease.
Clerkin KJ; Fried JA; Raikhelkar J; Sayer G; Griffin JM; Masoumi A; Jain SS; Burkhoff D; Kumaraiah D; Rabbani L; Schwartz A; Uriel N
Circulation; 2020 May; 141(20):1648-1655. PubMed ID: 32200663
[TBL] [Abstract][Full Text] [Related]
13. Off-target ACE2 ligands: Possible therapeutic option for CoVid-19?
Brogi S; Calderone V
Br J Clin Pharmacol; 2020 Jun; 86(6):1178-1179. PubMed ID: 32359080
[No Abstract] [Full Text] [Related]
14. Immunoglobulins in the treatment of COVID-19 infection: Proceed with caution!
Nguyen AA; Habiballah SB; Platt CD; Geha RS; Chou JS; McDonald DR
Clin Immunol; 2020 Jul; 216():108459. PubMed ID: 32418917
[TBL] [Abstract][Full Text] [Related]
15. Age-Dependent Sensory Impairment in COVID-19 Infection and its Correlation with ACE2 Expression.
Somekh I; Yakub Hanna H; Heller E; Bibi H; Somekh E
Pediatr Infect Dis J; 2020 Sep; 39(9):e270-e272. PubMed ID: 32658093
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 and chronic obstructive pulmonary disease: therapeutic potential of blocking SARS-CoV2 adhesion factors.
Shukla SD; Walters EH
Intern Med J; 2020 Sep; 50(9):1153-1154. PubMed ID: 32666683
[No Abstract] [Full Text] [Related]
17. Can beta-adrenergic blockers be used in the treatment of COVID-19?
Vasanthakumar N
Med Hypotheses; 2020 Sep; 142():109809. PubMed ID: 32388480
[No Abstract] [Full Text] [Related]
18. TMPRSS2: Potential Biomarker for COVID-19 Outcomes.
Strope JD; PharmD CHC; Figg WD
J Clin Pharmacol; 2020 Jul; 60(7):801-807. PubMed ID: 32437018
[No Abstract] [Full Text] [Related]
19. Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review.
Liya G; Yuguang W; Jian L; Huaiping Y; Xue H; Jianwei H; Jiaju M; Youran L; Chen M; Yiqing J
APMIS; 2020 Jun; 128(6):423-432. PubMed ID: 32363707
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of ACE2 induces overstimulation of the renin-angiotensin system in COVID-19: should we block the renin-angiotensin system?
Silhol F; Sarlon G; Deharo JC; Vaïsse B
Hypertens Res; 2020 Aug; 43(8):854-856. PubMed ID: 32439915
[No Abstract] [Full Text] [Related]
[Next] [New Search]
